Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 2/20 | 0.42 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.41 |
| ▸ | EP300 | Q09472 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9204861 | 1.00 | TSHR (0.48) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL410012 | 1.00 | TSHR (0.48) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL4140881 | 1.00 | TSHR (0.48) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL4023020 | 1.00 | TSHR (0.48) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL5323261 | 1.00 | TSHR (0.48) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL9205872 | 1.00 | TSHR (0.48) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL6984187 | 1.00 | TSHR (0.48) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL9206806 | 1.00 | TSHR (0.48) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL6246240 | 1.00 | TSHR (0.48) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL8080093 | 1.00 | TSHR (0.48) | TSHRTHRBFAAHTRPV1DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160237311-A1 | LOW DIELECTRIC CONSTANT, LOW DIELECTRIC DISSIPATION FACTOR COATINGS, FILMS AND ADHESIVES | MIZORI FARHAD G (US) | 2016-08-18 | — | — | US | claimed |
| WO-2015048575-A1 | LOW DIELECTRIC CONSTANT, LOW DIELECTRIC DISSIPATION FACTOR COATINGS, FILMS AND ADHESIVES | DESIGNER MOLECULES, INC. (US) | 2015-04-02 | — | — | WO | claimed |
| EP-0748357-B1 | AMINO AND FLUORO GROUP CONTAINING SILOXANES | DU PONT (US) | 1999-06-16 | — | — | EP | claimed |
| EP-4013385-B1 | IMPROVED LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS | ACUITAS THERAPEUTICS INC (CA) | 2024-07-03 | — | — | EP | disclosed |
| US-20240158458-A1 | MRNAS ENCODING IMMUNE MODULATING POLYPEPTIDES AND USES THEREOF | MODERNA TX INC (US) | 2024-05-16 | — | — | US | disclosed |
| US-11969506-B2 | Lipid nanoparticle formulation | MODERNATX, INC. (US) | 2024-04-30 | — | — | US | disclosed |
| US-20240124388-A1 | COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS | ARES CAPITAL CORPORATION, AS AGENT | 2024-04-18 | — | — | US | disclosed |
| US-20240024422-A1 | POLYNUCLEOTIDES ENCODING INTERLEUKIN-12 (IL12) AND USES THEREOF | ARES CAPITAL CORPORATION, AS AGENT | 2024-01-25 | — | — | US | disclosed |
| EP-3458105-B1 | POLYNUCLEOTIDES ENCODING GALACTOSE-1-PHOSPHATE URIDYLYLTRANSFERASE FOR THE TREATMENT OF GALACTOSEMIA TYPE 1 | MODERNATX INC (US) | 2024-01-17 | — | — | EP | disclosed |
| CN-117224710-A | Immunomodulatory therapeutic MRNA compositions encoding mutant peptides that activate oncogenes | 莫得纳特斯公司 | 2023-12-15 | — | — | CN | disclosed |
| EP-4286012-A2 | COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS | ModernaTX, Inc. (US) | 2023-12-06 | — | — | EP | disclosed |
| EP-0889097-A1 | PHTHALOCYANINE COMPOUNDS, PROCESS FOR PREPARING THE SAME, AND OPTICAL RECORDING MEDIUM MADE USING THE SAME | NIPPON SHOKUBAI CO., LTD. (JP) | 1999-01-07 | — | — | EP | disclosed |
| US-5851422-A | Polymeric material for liquid crystal/polymer composite film, record display medium, and use thereof | DAI NIPPON PRINTING CO., LTD. (JP) | 1998-12-22 | — | — | US | disclosed |
| EP-0790289-A1 | Polymeric material for liquid crystal/polymer composite film, liquid crystal/polymer composite film, record display medium, and use thereof | DAI NIPPON PRINTING CO., LTD. (JP) | 1997-08-20 | — | — | EP | disclosed |
| EP-0421441-B1 | Pantothenic acid derivatives | FUJIREBIO KK (JP) | 1995-01-25 | — | — | EP | disclosed |
| US-5120738-A | Cardiovascular disorders | FUJIREBIO INC. (JP) | 1992-06-09 | — | — | US | disclosed |
| EP-0421441-A2 | Pantothenic acid derivatives | FUJIREBIO INC. (JP) | 1991-04-10 | — | — | EP | disclosed |
| US-4737297-A | MONO-SUBSTITUTED NAPHTHALENES | NIPPON OIL CO., LTD. (JP) | 1988-04-12 | — | — | US | disclosed |
| US-4665275-A | OXIDATION-RESISTANT NAPHTHALENE DERIVATIVE | NIPPON OIL CO., LTD. (JP) | 1987-05-12 | — | — | US | disclosed |
| EP-0209990-A2 | Thermal transfer printing | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1987-01-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11969506-B2 | Lipid nanoparticle formulation | TTPA, SREBF1, SREBF2 | TSHR 1913/4885THRB 1782/4885FAAH 2258/4885 |
| US-20240024422-A1 | POLYNUCLEOTIDES ENCODING INTERLEUKIN-12 (IL12) AND USES THEREOF | IL2, IL15, RBM12 | TSHR 3940/4885THRB 4329/4885FAAH 4084/4885 |
| US-20240124388-A1 | COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS | LNPK, PLTP, PLIN3 | TSHR 3089/4885THRB 3096/4885FAAH 3137/4885 |
| US-20240158458-A1 | MRNAS ENCODING IMMUNE MODULATING POLYPEPTIDES AND USES THEREOF | IL2, LCP2, IFNG | TSHR 1274/4885THRB 2469/4885FAAH 3346/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.